Researchers have found the mechanism of action for cancer-cell-killing peptides. This research is expected to lead to better medication, in particular better treatments for leukemia, skin cancer, and infections caused by multi-resistant bacteria. Thanks to this new knowledge, it is hoped that future medical therapies will be more effective and have far fewer side effects. The first trials on patients are expected to take place over the next two years and the first finished products should be entering the market ten years from now.